Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153527 | SCV000203055 | benign | not specified | 2017-10-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000153527 | SCV000269381 | benign | not specified | 2014-11-26 | criteria provided, single submitter | clinical testing | This is a RefSeq error. The reference base (c.220A) is the minor allele. This al lele (A) has been identified in 4% (193/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs 6890689) and thus meets criteria to be classified as benign. |
ARUP Laboratories, |
RCV000987603 | SCV001156894 | benign | Myofibrillar myopathy 3 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000987603 | SCV001728007 | benign | Myofibrillar myopathy 3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001636695 | SCV001847906 | benign | not provided | 2021-03-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27884173, 15947064, 25617006, 20981092, 22995991) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000153527 | SCV003928315 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000153527 | SCV001739862 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000153527 | SCV001920372 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001636695 | SCV001932037 | likely benign | not provided | no assertion criteria provided | clinical testing |